Business Context and Reporting Period
Company: Bruker Corporation
Filing Type: Form 8-K (Current Report)
Date of Report: January 12, 2011
Context: The filing announces the Company's participation in the 29th Annual J.P. Morgan Healthcare Conference. It serves to disclose previously non-public information regarding preliminary, unaudited revenue estimates for the fourth quarter of fiscal 2010.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. It references the existence of preliminary, unaudited revenue estimates for the fourth quarter of fiscal 2010 contained in the attached presentation materials (Exhibit 99.1, slide 16), but the specific figures are not included in the body of this report.
Material Changes
No material changes versus prior periods are quantified in this document. The filing solely acts as a disclosure mechanism for the preliminary Q4 2010 revenue estimates to be presented at the conference.
Guidance, Outlook, and Risks
Management Commentary: Management will present the preliminary revenue estimates at the J.P. Morgan Healthcare Conference in San Francisco.
Regulatory Status: The information is furnished under Regulation FD and is not deemed "filed" for purposes of Section 18 of the Exchange Act, nor is it incorporated by reference into other filings unless specifically identified.
Availability: The presentation slides are available on the Company's investor relations website.
Investor Verification Checklist
- Verify the specific preliminary, unaudited revenue figures for Q4 fiscal 2010 by reviewing Exhibit 99.1 (slide 16) attached to the filing or the presentation on the investor relations website.
- Confirm the final audited results for fiscal 2010 when the official 10-K is released to compare against these preliminary estimates.
- Review the full presentation materials for any additional context regarding the revenue estimates that is not captured in this summary.